KEGG   ORTHOLOGY: K04853
Entry
K04853                      KO                                     

Name
CACNA1F, CAV1.4
Definition
voltage-dependent calcium channel L type alpha-1F
Pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04260  Cardiac muscle contraction
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04723  Retrograde endocannabinoid signaling
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04921  Oxytocin signaling pathway
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04927  Cortisol synthesis and secretion
ko04929  GnRH secretion
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko05010  Alzheimer disease
ko05020  Prion disease
ko05022  Pathways of neurodegeneration - multiple diseases
ko05410  Hypertrophic cardiomyopathy
ko05412  Arrhythmogenic right ventricular cardiomyopathy
ko05414  Dilated cardiomyopathy
Disease
H00481  Cone-rod dystrophy and cone dystrophy
H00690  Aland Island eye disease
H00787  Congenital stationary night blindness
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04020 Calcium signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04024 cAMP signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04022 cGMP-PKG signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
 09150 Organismal Systems
  09152 Endocrine system
   04911 Insulin secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04929 GnRH secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04912 GnRH signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04921 Oxytocin signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04935 Growth hormone synthesis, secretion and action
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04924 Renin secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04925 Aldosterone synthesis and secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04927 Cortisol synthesis and secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09153 Circulatory system
   04260 Cardiac muscle contraction
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04261 Adrenergic signaling in cardiomyocytes
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04270 Vascular smooth muscle contraction
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09156 Nervous system
   04727 GABAergic synapse
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04725 Cholinergic synapse
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04726 Serotonergic synapse
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04723 Retrograde endocannabinoid signaling
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05020 Prion disease
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05022 Pathways of neurodegeneration - multiple diseases
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09166 Cardiovascular disease
   05410 Hypertrophic cardiomyopathy
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05412 Arrhythmogenic right ventricular cardiomyopathy
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05414 Dilated cardiomyopathy
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
Ion channels [BR:ko04040]
 Voltage-gated cation channels
  Calcium channel, voltage-gated (Cav)
   K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
Other DBs
GO: 0005245
TC: 1.A.1.11.11
Genes
HSA: 778(CACNA1F)
PTR: 740711(CACNA1F)
PPS: 100988624(CACNA1F)
GGO: 101131714(CACNA1F)
PON: 100431752(CACNA1F)
NLE: 100590475(CACNA1F)
MCC: 715787(CACNA1F)
MCF: 102119841(CACNA1F)
CSAB: 103231971(CACNA1F)
RRO: 104661816(CACNA1F)
RBB: 108521361
CJC: 100386041(CACNA1F)
SBQ: 101034685(CACNA1F)
MMU: 54652(Cacna1f)
MCAL: 110286673(Cacna1f)
MPAH: 110313596(Cacna1f)
RNO: 114493(Cacna1f)
MUN: 110561910(Cacna1f)
CGE: 100757994(Cacna1f)
NGI: 103741673(Cacna1f)
HGL: 101722090(Cacna1f)
CCAN: 109697195(Cacna1f)
OCU: 100357261(CACNA1F)
TUP: 102482779(CACNA1F)
CFA: 480915(CACNA1F)
VVP: 112907237(CACNA1F)
AML: 100468661(CACNA1F)
UMR: 103667625(CACNA1F)
UAH: 113265950(CACNA1F)
ORO: 101364481(CACNA1F)
ELK: 111150407
FCA: 101080870(CACNA1F)
PTG: 102950547(CACNA1F)
PPAD: 109248097(CACNA1F)
AJU: 106988999(CACNA1F)
BTA: 509779(CACNA1F)
BOM: 102286805(CACNA1F)
BIU: 109554975(CACNA1F)
BBUB: 102407399(CACNA1F)
CHX: 102189746(CACNA1F)
OAS: 101104552(CACNA1F)
SSC: 100514745(CACNA1F)
CFR: 102504151(CACNA1F)
CDK: 105103284(CACNA1F)
BACU: 102998540(CACNA1F)
LVE: 103082192(CACNA1F)
OOR: 101281199(CACNA1F)
DLE: 111169490(CACNA1F)
PCAD: 102992313(CACNA1F)
ECB: 100062861(CACNA1F)
EPZ: 103543955(CACNA1F)
EAI: 106826963(CACNA1F)
MYB: 102260789(CACNA1F)
MYD: 102771414(CACNA1F)
MNA: 107541372(CACNA1F)
HAI: 109374806(CACNA1F)
DRO: 112322357(CACNA1F)
PALE: 102893611(CACNA1F)
RAY: 107514999(CACNA1F)
MJV: 108404213(CACNA1F)
LAV: 100674649(CACNA1F)
TMU: 101340818
MDO: 100019531(CACNA1F)
SHR: 100927554(CACNA1F)
PCW: 110201034(CACNA1F)
OAA: 100075939(CACNA1F)
LSR: 110482322
FAB: 101817703
PHI: 102111116(CACNA1F)
FPG: 101922071
FCH: 102046341
CLV: 102089966
AAM: 106493905(CACNA1F)
ASN: 102368804(CACNA1F)
AMJ: 102563169(CACNA1F)
CPIC: 101934179(CACNA1F)
ACS: 100565753(cacna1f)
PVT: 110078615(CACNA1F)
PBI: 103051695(CACNA1F)
PMUR: 107284195(CACNA1F)
PMUA: 114587594(CACNA1F)
GJA: 107117359
XLA: 100462913(cacna1f.L)
XTR: 100485906(cacna1f)
NPR: 108788491
DRE: 559964(cacna1fb) 793708(cacna1fa)
SRX: 107723069 107731232 107745766 107756819
SANH: 107668072 107695300
SGH: 107548248 107549945 107550115
CCAR: 109065543 109087149
IPU: 108265065 108265094(cacna1f)
PHYP: 113528653 113533319
AMEX: 103033957 103034295
EEE: 113578747(cacna1f) 113579098
TRU: 101077620(cacna1f) 101079199
TNG: GSTEN00023513G001 GSTEN00026488G001
LCO: 104933125 104935494
MZE: 101480057
ONL: 100700615 100706871
OLA: 101171727 101171913
XMA: 102223947 102230940
XCO: 114141072 114141251
PRET: 103460216 103467718
CVG: 107095949(cacna1f) 107099706
NFU: 107390498(cacna1f) 107391407
KMR: 108228711 108232078
ALIM: 106519282(cacna1f) 106523414 106533880
AOCE: 111580242
CSEM: 103384398 103385395(cacna1f)
POV: 109642986 109643812
LCF: 108882181 108890565
SDU: 111234857 111235435
SLAL: 111654197 111669629
HCQ: 109510493 109512986(cacna1f)
BPEC: 110154433 110164475(cacna1f)
MALB: 109953071
SASA: 106572493
OTW: 112221526
SALP: 111966955
ELS: 105008776 105022404
SFM: 108918279 108934768
PKI: 111847817 111857113
LCM: 102353236(CACNA1F)
 » show all
Reference
  Authors
Lee A, Wang S, Williams B, Hagen J, Scheetz TE, Haeseleer F
  Title
Characterization of Cav1.4 complexes (alpha11.4, beta2, and alpha2delta4) in HEK293T cells and in the retina.
  Journal
J Biol Chem 290:1505-21 (2015)
DOI:10.1074/jbc.M114.607465
  Sequence
[hsa:778]
Reference
PMID:9662399
  Authors
Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, Ruther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A
  Title
An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness.
  Journal
Nat Genet 19:260-3 (1998)
DOI:10.1038/940
  Sequence
[hsa:778]
LinkDB

DBGET integrated database retrieval system